IIL, CIFE join hands to develop fish vaccine
The new vaccines will tackle common bacterial diseases in freshwater fishes
image for illustrative purpose
Hyderabad: City-based vaccine manufacturer Indian Immunologicals Limited (IIL) announced its partnership with Central Institute of Fisheries Education (CIFE), a Mumbai-based Indian Council of Agricultural Research Institute, for the commercial development of vaccine against common bacterial diseases in freshwater fishes.
Under this tie-up, CIFE will provide technology for two inactivated bacterial vaccines, one for Columnaris disease, a condition affecting freshwater fish species, and other for Edwardsiellosis that cause high degree of mortality, leading to severe economic losses. Dr K Anand Kumar, Managing Director, Indian Immunologicals Limited, said, "We are committed to introducing new products in the aquaculture market to support shrimp and fish farmers.
These vaccines will increase productivity and protect fish schools from various diseases." With the launch of products for aquaculture market, IIL forayed into aqua business in October 2022. "IIL is planning to introduce vaccines and immune stimulants with tech transfer from various fisheries institutes under ICAR. Several fish vaccine candidates are currently being evaluated by IIL for commercialization," Dr Priyabrata Pattnaik, Deputy MD, IIL added.
